
1. j virol. 2006 sep;80(18):8951-60.

dc-sign clec-2 mediate human immunodeficiency virus type 1 capture by
platelets.

chaipan c(1), soilleux ej, simpson p, hofmann h, gramberg t, marzi a, geier m,
stewart ea, eisemann j, steinkasserer a, suzuki-inoue k, fuller gl, pearce ac,
watson sp, hoxie ja, baribaud f, pöhlmann s.

author information: 
(1)nikolaus-fiebiger-center molecular medicine, university erlangen-nürnberg,
glückstrasse 6, 91054 erlangen, germany.

platelets engulf human immunodeficiency virus type 1 (hiv-1), a
significant amount hiv-1 blood infected individuals associated
with cells. however, unclear platelets capture hiv-1 whether 
platelet-associated virus remains infectious. dc-sign lectins
contribute capture hiv-1 dendritic cells (dcs) facilitate hiv-1
spread dc/t-cell cocultures. here, show platelets express the
c-type lectin-like receptor 2 (clec-2) low levels dc-sign. clec-2 bound to
hiv-1, irrespective presence viral envelope protein, and
facilitated hiv-1 capture platelets. however, substantial fraction the
hiv-1 binding activity platelets dependent dc-sign. combination of
dc-sign clec-2 inhibitors strongly reduced hiv-1 association platelets, 
indicating lectins required efficient hiv-1 binding to
platelets. captured hiv-1 maintained infectious state several
days, suggesting hiv-1 escape degradation platelets might use
these cells promote spread. results identify clec-2 novel hiv-1
attachment factor provide evidence platelets capture transfer
infectious hiv-1 via dc-sign clec-2, thereby possibly facilitating hiv-1
dissemination infected patients.

doi: 10.1128/jvi.00136-06 
pmcid: pmc1563896
pmid: 16940507  [indexed medline]

